Confronting the Care Delivery Challenges Arising from Precision Medicine
Author:
Funder
Division of Cancer Treatment and Diagnosis, and National Cancer Institute
National Cancer Institute
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference40 articles.
1. Ovarian cancer;Jayson;Lancet,2014
2. Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs;Cummings;Br J Cancer,2010
3. Proteomics as a guiding tool for more effective personalized therapy;Lee;Ann Oncol,2010
4. The therapeutic challenge of targeting HER2 in endometrial cancer;Diver;Oncologist,2015
5. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;J Clin Oncol,2013
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report;JCO Precision Oncology;2022-10
2. Patient-Friendly HIT Tools and the Advent of Crowdsourcing Clinical Trials;Implementing Precision Medicine in Best Practices of Chronic Airway Diseases;2019
3. Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine;Progress in Retinal and Eye Research;2017-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3